PDPN and non-small cell lung carcinoma: Mathieson et al. identified that specific CAF subpopulations expressing FAP and podoplanin in NSCLC serve as predictors of poor clinical outcomes, highlighting the importance of characterizing CAF subtypes in NSCLC [64].